11-77039726-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138706.5(B3GNT6):c.175G>A(p.Glu59Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,605,436 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138706.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B3GNT6 | NM_138706.5 | c.175G>A | p.Glu59Lys | missense_variant | 2/2 | ENST00000622824.1 | NP_619651.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B3GNT6 | ENST00000622824.1 | c.175G>A | p.Glu59Lys | missense_variant | 2/2 | 1 | NM_138706.5 | ENSP00000484640 | P1 | |
B3GNT6 | ENST00000528622.5 | c.175G>A | p.Glu59Lys | missense_variant | 3/3 | 3 | ENSP00000435628 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000439 AC: 99AN: 225442Hom.: 0 AF XY: 0.000385 AC XY: 48AN XY: 124642
GnomAD4 exome AF: 0.000232 AC: 337AN: 1453128Hom.: 1 Cov.: 30 AF XY: 0.000230 AC XY: 166AN XY: 722534
GnomAD4 genome AF: 0.000230 AC: 35AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.175G>A (p.E59K) alteration is located in exon 2 (coding exon 1) of the B3GNT6 gene. This alteration results from a G to A substitution at nucleotide position 175, causing the glutamic acid (E) at amino acid position 59 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at